Regulated Information - Transparency Statement

Baron Philippe Vlerick increases shareholding ThromboGenics NV to 6.4%

Leuven, Belgium, 10 September 2015 - Pursuant to Belgian transparency legislation (Law of 2 May 2007), ThromboGenics NV (Euronext Brussels: THR) received a transparency notification on 9 September 2015 from Philippe Vlerick and controlled entities.

Philippe Vlerick (Bareldam SA) notified that on 9 September 2015, 2,324,719 shares, representing 6.44% of the current 36,094,349 outstanding ThromboGenics shares, were held by himself and controlled entities.

On September 9, 2015, based on all received transparency declarations received, ThromboGenics NV is aware of the following participations:

distributed by